D. Souery

发表

Combining clinical variables to optimize prediction of antidepressant treatment outcomes.

M. Rietschel, A. Farmer, P. McGuffin, 2016, Journal of psychiatric research.

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

M. Rietschel, A. Elkin, A. Farmer, 2009, British Journal of Psychiatry.

Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study

M. Rietschel, R. Kaneva, A. Serretti, 2005, Molecular Psychiatry.

5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder

P. Verbanck, Y. Lecrubier, S. Kasper, 2010, International clinical psychopharmacology.

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

Julien Mendlewicz, Siegfried Kasper, Koen Demyttenaere, 2007, The Journal of clinical psychiatry.

Failure to Replicate Influence of GRIK4 and GNB3 Polymorphisms on Treatment Outcome in Major Depression

A. Serretti, Y. Lecrubier, S. Kasper, 2012, Neuropsychobiology.

Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: a case-control study.

Y. Osher, D. Souery, M. Gorfine, 1999, Comprehensive psychiatry.

Identification of a CACNA2D4 deletion in late onset bipolar disorder patients and implications for the involvement of voltage‐dependent calcium channels in psychiatric disorders

D. Grozeva, N. Craddock, E. Green, 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes.

C. Broeckhoven, J. Mendlewicz, D. Souery, 1996, American journal of medical genetics.

Antidepressant Response in Major Depressive Disorder: A Genome-wide Association Study

N. Wray, M. Rietschel, W. Maier, 2020, medRxiv.

Chromosome 10q harbors a susceptibility locus for bipolar disorder in Ashkenazi Jewish families

C. Broeckhoven, S. Claes, D. Souery, 2008, Molecular Psychiatry.

Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study

R. Kaneva, A. Serretti, C. Broeckhoven, 2003, European Neuropsychopharmacology.

Excess of allele1 for α3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study

M. Rietschel, R. Kaneva, A. Serretti, 2002, Molecular Psychiatry.

The GABAergic Hypothesis of Mood Disorders

G. Papadimitriou, J. Mendlewicz, D. Souery, 2000 .

Pharmacogenetics of antidepressant response: A polygenic approach antidepressant A

K. Tansey, W. Maier, O. Mors, 2017 .

Pharmacogenetics of antidepressant response: A polygenic approach. Progress in Neuro-Psychopharmacology and

Katherine, M. Rietschel, G. Breen, 2016 .

Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: a multicenter association study.

R. Kaneva, A. Serretti, Marina Heiden, 1999, American journal of medical genetics.

HOW AN INTERNIST SHOULD DEAL WITH PSYCHOTROPIC DRUGS ?

D. Souery, 2004, Acta clinica Belgica.

Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients

A. Serretti, J. Mendlewicz, D. Souery, 2014, Journal of Neural Transmission.

The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs.

D. Rujescu, A. Serretti, L. Bartova, 2022, Journal of Affective Disorders.

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries

D. Rujescu, A. Serretti, L. Bartova, 2022, European Archives of Psychiatry and Clinical Neuroscience.

A novel CpG-associated brain-expressed candidate gene for chromosome 18q-linked bipolar disorder

P. D. Rijk, C. Broeckhoven, S. Claes, 2002, Molecular Psychiatry.

Lack of genetic association between the phospholipase A2 gene and bipolar mood disorder in a European multicentre case–control study

S. Cichon, M. Rietschel, M. Nöthen, 2006, Psychiatric genetics.

Drug repositioning for treatment-resistant depression: insights from a pharmacogenomic study

Albani, D. Rujescu, A. Serretti, 2020 .

The Impact of Adverse Life Events on Clinical Features and Interaction with Gene Variants in Mood Disorder Patients

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Psychopathology.

Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders.

S. Claes, J. Mendlewicz, D. Souery, 2005, The international journal of neuropsychopharmacology.

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders.

L. Peltonen, R. Kaneva, A. Serretti, 2002, American journal of medical genetics.

No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism

C. Broeckhoven, J. Mendlewicz, D. Souery, 1997, Psychiatry Research.

Molecular Genetics and Mood Disorders

D. Souery, J. Mendlewicz, 2003 .

Molecular genetic and family studies in affective disorders: state of the art.

D. Souery, J. Mendlewicz, S. Rivelli, 2001, Journal of affective disorders.

Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting

D. Rujescu, A. Serretti, S. Kasper, 2022, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression.

A. Serretti, L. Bartova, S. Kasper, 2021, Journal of psychiatric research.

Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients.

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Journal of affective disorders.

Polygenic risk scores for psychiatric, inflammatory, and cardio-metabolic traits and diseases highlight possible genetic overlaps with suicide attempt and treatment-emergent suicidal ideation European College of Neuropsychopharmacology (ECNP) Network on Suicide Research and Prevention,

D. Rujescu, D. Souery, J. Zohar, 2021 .

Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns.

D. Rujescu, A. Serretti, S. Kasper, 2022, Journal of affective disorders.

Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.

A. Serretti, L. Bartova, S. Kasper, 2019, The Journal of clinical psychiatry.

P.021 Social dysfunction in mood disorders and schizophrenia: clinical correlates in four independent samples

D. Rujescu, A. Serretti, S. Kasper, 2019, European Neuropsychopharmacology.

Self-esteem, social adjustment and suicidality in affective disorders

C. Stefanis, G. Papadimitriou, J. Mendlewicz, 2002, European Psychiatry.

Short-term and long-term treatment for bipolar patients: beyond the guidelines.

J. Mendlewicz, D. Souery, S. Rivelli, 1999, Journal of affective disorders.

Molecular genetics of aﬀective disorders

J. Mendlewicz, D. Souery, P. Oswald, 2003 .

Excess tyrosine hydroxylase restriction fragment length polymorphism homozygosity in unipolar but not bipolar patients: A preliminary report

C. Broeckhoven, J. Mendlewicz, D. Souery, 1996, Biological Psychiatry.

Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression

D. Rujescu, C. Lewis, A. Serretti, 2020, medRxiv.

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

A. Serretti, S. Kasper, J. Mendlewicz, 2014, The Pharmacogenomics Journal.

Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression

A. Serretti, S. Kasper, J. Mendlewicz, 2012, Neuroscience Letters.

Molecular genetics in the analysis of suicide

P. Linkowski, J. Mendlewicz, D. Souery, 2003, Annals of medicine.

Social adjustment and self-esteem in remitted patients with mood disorders

A. Serretti, E. Smeraldi, J. Mendlewicz, 1999, European Psychiatry.

Lack of association between GABRA3 and unipolar affective disorder: a multicentre study.

R. Kaneva, V. Milanova, G. Papadimitriou, 2001, The international journal of neuropsychopharmacology.

Treatment resistant depression: methodological overview and operational criteria

J. Amsterdam, C. Montigny, Y. Lecrubier, 1999, European Neuropsychopharmacology.

Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression

A. Serretti, Y. Lecrubier, S. Kasper, 2011, Journal of clinical psychopharmacology.

Social adjustment and self-esteem of bipolar patients: a multicentric study.

R. Kaneva, A. Serretti, G. Papadimitriou, 2004, Journal of affective disorders.

Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples

D. Rujescu, B. Penninx, A. Serretti, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables

M. Rietschel, A. Farmer, P. McGuffin, 2018, Scientific Reports.

Adverse reactions to antidepressants.

Marcella Rietschel, Erik Roj Larsen, Peter McGuffin, 2009, The British journal of psychiatry : the journal of mental science.

Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples

A. Serretti, J. Mendlewicz, D. Souery, 2013, Journal of psychopharmacology.

Familiality and SNP heritability of age at onset and episodicity in major depressive disorder

John P. Rice, M. Rietschel, M. Gill, 2015, Psychological Medicine.

University of Birmingham Familiality and SNP heritability of age at onset and episodicity in major depressive disorder

M. Rietschel, M. Gill, N. Craddock, 2015 .

Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder

D. Rujescu, A. Serretti, S. Kasper, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not?

D. Blackwood, B. Pickard, J. Mendlewicz, 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Genetic refinement and physical mapping of a chromosome 18q candidate region for bipolar disorder

C. Broeckhoven, J. Mendlewicz, D. Souery, 1999, European Journal of Human Genetics.

Contributions of Molecular Genetics to the Understanding of Bipolar Depression

D. Souery, J. Mendlewicz, 1998 .

Molecular Genetics of Mental Disorders with Particular Reference to Affective Disorders

D. Souery, J. Mendlewicz, O. Lipp, 1997, European Psychiatry.

Linkage analysis of families with bipolar illness and chromosome 18 markers

C. Broeckhoven, J. Mendlewicz, D. Souery, 1996, Biological Psychiatry.

Molecular genetics of affective disorders

J. Mendlewicz, D. Souery, P. Oswald, 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Molecular genetics of affective disorders.

J. Mendlewicz, D. Souery, P. Oswald, 2003, The international journal of neuropsychopharmacology.

Linkage of mood disorders with D2, D3 and TH genes: a multicenter study.

C. Stefanis, R. Kaneva, C. Cusin, 2000, Journal of affective disorders.

Genetic association between the phospholipase A2 gene and unipolar affective disorder: a multicentre case–control study

S. Cichon, M. Rietschel, M. Nöthen, 2003, Psychiatric genetics.

Expanded trinucleotide CAG repeats in families with bipolar affective disorder

C. Broeckhoven, J. Mendlewicz, D. Souery, 1997, Biological Psychiatry.

Genetics of bipolar disorders

D. Souery, I. Massat, J. Mendlewicz, 2000, Acta Neuropsychiatrica.

Molecular genetic findings in mood disorders

D. Souery, J. Mendlewicz, 1999, Acta Neuropsychiatrica.

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study

A. Serretti, S. Kasper, J. Mendlewicz, 2017, The international journal of neuropsychopharmacology.

Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression

A. Serretti, S. Kasper, J. Mendlewicz, 2015, The International journal of neuroscience.

Genome-wide association study of co-occurring anxiety in major depression

M. Rietschel, M. Gill, N. Craddock, 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk—a European multicentre study on treatment-resistant major depressive disorder

A. Serretti, S. Kasper, J. Mendlewicz, 2013, European Archives of Psychiatry and Clinical Neuroscience.

The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder — A European Multicenter Study

A. Serretti, S. Kasper, D. Souery, 2012, European Neuropsychopharmacology.

Molecular Interpretation of Expanded RED Products in Bipolar Disorder by CAG/CTG Repeats Located at Chromosomes 17q and 18q

K. Lindblad, C. Broeckhoven, J. Mendlewicz, 1999, Neurobiology of Disease.

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies

M. Rietschel, K. Tansey, I. Craig, 2018, European Neuropsychopharmacology.

European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings

A. Serretti, S. Kasper, J. Mendlewicz, 2012, European Neuropsychopharmacology.

Genetic variants associated with psychotic symptoms across psychiatric disorders

A. Serretti, L. Mandelli, S. Kasper, 2020, Neuroscience Letters.

Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation

D. Rujescu, A. Serretti, D. Wasserman, 2022, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Identifying the Common Genetic Basis of Antidepressant Response

M. Rietschel, W. Maier, B. Mulsant, 2021, Biological psychiatry global open science.

Polygenic risk scores for psychiatric, inflammatory, and cardio-metabolic traits and diseases highlight possible genetic overlaps with suicide attempt and treatment-emergent suicidal ideation

D. Rujescu, A. Serretti, D. Wasserman, 2021, medRxiv.

Bipolar II disorder as a risk factor for postpartum depression.

A. Serretti, L. Mandelli, L. Bartova, 2016, Journal of affective disorders.

Clinical and genetic factors associated with suicide in mood disorder patients

A. Serretti, J. Mendlewicz, D. Souery, 2016, European Archives of Psychiatry and Clinical Neuroscience.

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

J. Calabrese, J. Amsterdam, A. Young, 2013, The American journal of psychiatry.

Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study

D. Rujescu, A. Serretti, S. Kasper, 2022, European Neuropsychopharmacology.

Manic-depressive illness and linkage reanalysis in the Xq27-Xq28 region of chromosome X.

J. Mendlewicz, S. Sevy, D. Souery, 1995, Neuropsychobiology.

Noradrenaline in mood and anxiety disorders: basic and clinical studies

L. Judd, J. Mendlewicz, D. Souery, 2003, International clinical psychopharmacology.

Depression across mood disorders: review and analysis in a clinical sample.

A. Serretti, J. Mendlewicz, D. Souery, 2012, Comprehensive psychiatry.

Comorbid hypertension in patients with major depressive disorder – Results from a European multicenter study

A. Serretti, L. Bartova, S. Kasper, 2019, European Neuropsychopharmacology.

Investigation of blood mRNA biomarkers for suicidality in an independent sample

M. Rietschel, K. Tansey, G. Breen, 2014, Translational Psychiatry.

Copy number variants and therapeutic response to antidepressant medication in major depressive disorder

T. Peters, M. Rietschel, K. Tansey, 2014, The Pharmacogenomics Journal.

Non‐replication of the brain‐derived neurotrophic factor (BDNF) association in bipolar affective disorder: A Belgian patient‐control study

S. Claes, J. Mendlewicz, D. Souery, 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives

D. Rujescu, A. Serretti, S. Kasper, 2018, The international journal of neuropsychopharmacology.

Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)

M. Rietschel, I. Craig, G. Breen, 2018, Translational Psychiatry.

Manic depressive disorder and chromosome 18

C. Broeckhoven, J. Mendlewicz, D. Souery, 1998 .

In search of anticipation in unipolar affective disorder

C. Broeckhoven, J. Mendlewicz, D. Souery, 2005, European Neuropsychopharmacology.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study

S. Kasper, J. Mendlewicz, D. Souery, 2010, International clinical psychopharmacology.

The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder

D. Rujescu, A. Serretti, L. Bartova, 2021, The international journal of neuropsychopharmacology.

A New Characterization of Mental Health Disorders Using Digital Behavioral Data: Evidence from Major Depressive Disorder

D. Souery, D. Taliaz, 2021, Journal of clinical medicine.

Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.

E. Constant, P. Sienaert, S. Claes, 2010 .

Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project

M. Rietschel, I. Craig, G. Breen, 2010, The Pharmacogenomics Journal.

Exploring the role of drug-metabolising enzymes in antidepressant side effects

M. Rietschel, K. Tansey, I. Craig, 2015, Psychopharmacology.

Genetic predictors of antidepressant side effects: A grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study

M. Rietschel, A. Farmer, P. McGuffin, 2014, Journal of psychopharmacology.

Genome-Based Therapeutic Drugs for Depression ( GENDEP ) study Genetic predictors of antidepressant side effects : A grouped candidate gene approach in the

M. Rietschel, A. Farmer, P. McGuffin, 2014 .

Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis

T. Peters, M. Rietschel, K. Tansey, 2012, PLoS medicine.

Variation in GNB3 predicts response and adverse reactions to antidepressants

M. Rietschel, I. Craig, A. Elkin, 2011, Journal of psychopharmacology.

Changes in body weight during pharmacological treatment of depression.

M. Rietschel, A. Farmer, P. McGuffin, 2011, The international journal of neuropsychopharmacology.

Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the 5-HTTLPR

M. Rietschel, A. Farmer, P. McGuffin, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Moderation of antidepressant response by the serotonin transporter gene

M. Rietschel, I. Craig, A. Farmer, 2009, British Journal of Psychiatry.

Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project

M. Rietschel, I. Craig, A. Farmer, 2011, The Pharmacogenomics Journal.

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

M. Rietschel, A. Farmer, P. McGuffin, 2011, Psychological Medicine.

Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.

M. Rietschel, A. Farmer, P. McGuffin, 2011, Journal of affective disorders.

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

P. Muglia, M. Rietschel, T. Schulze, 2010, The American journal of psychiatry.

Genetic predictors of response to antidepressants in the GENDEP project

Thomas G Schulze, Marcella Rietschel, Erik Roj Larsen, 2009, The Pharmacogenomics Journal.

Association between novelty-seeking and the dopamine D3 receptor gene in bipolar patients: a preliminary report.

D. Souery, F. Hentges, O. Le Bon, 1998, American journal of medical genetics.

Expanded RED products and loci containing CAG/CTG repeats on chromosome 17 (ERDA1) and chromosome 18 (CTG18.1) in trans‐generational pairs with bipolar affective disorder

K. Lindblad, J. Mendlewicz, D. Souery, 2004, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

No evidence for the involvement of CAG/CTG repeats from within 18q21.33–q23 in bipolar disorder

C. Broeckhoven, S. Claes, J. Mendlewicz, 2000, European Journal of Human Genetics.

New molecular genetic findings in the genetics of affective disorders

D. Souery, J. Mendlewicz, 1997, Acta Neuropsychiatrica.

A linkage study between bipolar disorder and genes involved in dopaminergic and GABAergic neurotransmission

J. Mendlewicz, D. Souery, C. van Broeckhoven, 1996, Psychiatric genetics.

Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)

A. Serretti, L. Bartova, S. Kasper, 2018, European Neuropsychopharmacology.

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)

A. Serretti, L. Bartova, S. Kasper, 2018, The international journal of neuropsychopharmacology.

Genetic analysis of the 12Q candidate region for bipolar disorder

C. Broeckhoven, S. Claes, J. Mendlewicz, 1998 .

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance

A. Serretti, S. Kasper, J. Mendlewicz, 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder

C. Broeckhoven, S. Claes, J. Mendlewicz, 2007, Psychiatry Research.

Phenomenology of psychotic mood disorders: lifetime and major depressive episode features.

A. Serretti, S. Kasper, J. Mendlewicz, 2011, Journal of affective disorders.

Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features.

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes – Results from a cross-sectional European multicenter study

A. Serretti, L. Bartova, S. Kasper, 2017, European Neuropsychopharmacology.

Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection method

K. Lindblad, C. Broeckhoven, J. Mendlewicz, 1995 .

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping

D. Rujescu, C. Lewis, A. Serretti, 2019, Translational Psychiatry.

Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice

A. Serretti, L. Bartova, S. Kasper, 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.

Stephan Ripke, Steven P. Hamilton, Florian Holsboer, 2013, The American journal of psychiatry.

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance

A. Serretti, S. Kasper, J. Mendlewicz, 2017, European Archives of Psychiatry and Clinical Neuroscience.

Convergent Animal and Human Evidence Suggests a Role of PPM1A Gene in Response to Antidepressants

M. Rietschel, I. Craig, A. Farmer, 2011, Biological Psychiatry.

History of suicide attempts among patients with depression in the GENDEP project.

M. Rietschel, A. Farmer, P. McGuffin, 2010, Journal of affective disorders.

Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial

M. Rietschel, A. Elkin, A. Farmer, 2009, BMC medicine.

Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder

M. Rietschel, R. Kaneva, A. Serretti, 2000, Molecular Psychiatry.

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

D. Rujescu, C. Lewis, A. Serretti, 2018, British Journal of Psychiatry.

Pharmacogenetics of antidepressant response: A polygenic approach

T. Peters, M. Rietschel, T. Schulze, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder

M. Rietschel, A. Farmer, P. McGuffin, 2012, Psychological Medicine.

Body weight as a predictor of antidepressant efficacy in the GENDEP project.

M. Rietschel, A. Farmer, P. McGuffin, 2009, Journal of affective disorders.

Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder

M. Rietschel, A. Farmer, P. McGuffin, 2019, British Journal of Psychiatry.

Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression

M. Rietschel, K. Tansey, A. Farmer, 2017, Brain, Behavior, and Immunity.

Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study.

A. Serretti, S. Kasper, J. Mendlewicz, 2016, Journal of affective disorders.

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.

K. Tansey, A. Farmer, P. McGuffin, 2014, The American journal of psychiatry.

Dissecting the Genetic Heterogeneity of Depression Through Age at Onset

John P. Rice, P. Muglia, M. Rietschel, 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Trajectories of change in depression severity during treatment with antidepressants

M. Rietschel, A. Farmer, P. McGuffin, 2009, Psychological Medicine.

Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project

M. Rietschel, T. Schulze, I. Craig, 2009, Neuropsychopharmacology.

Transcriptomics and the mechanisms of antidepressant efficacy

M. Rietschel, K. Tansey, I. Craig, 2016, European Neuropsychopharmacology.

Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study

M. Rietschel, M. Nöthen, R. Kaneva, 2004, European Journal of Human Genetics.

A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression

C. Duijn, C. Broeckhoven, S. Claes, 2003, Molecular Psychiatry.

Methodology for clinical genotyping of CYP2D6 and CYP2C19

M. Rietschel, W. Maier, O. Mors, 2021, Translational Psychiatry.

Cross-validation of technologies for genotyping CYP2D6 and CYP2C19

Bahareh Behroozi Asl, M. Rietschel, W. Maier, 2019, bioRxiv.

Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients

A. Serretti, Y. Lecrubier, S. Kasper, 2009, International clinical psychopharmacology.

Neuronal cell adhesion genes and antidepressant response in three independent samples

A. Serretti, D. Gurwitz, S. Kasper, 2015, The Pharmacogenomics Journal.

New insights on the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

M. Rietschel, K. Tansey, G. Breen, 2017, bioRxiv.

Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study

D. Rujescu, C. Lewis, A. Serretti, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

P.335 Drug repositioning for treatment-resistant depression by comparing genetic predictors with known drug targets

D. Rujescu, A. Serretti, S. Kasper, 2020, European Neuropsychopharmacology.

Genetic differences in cytochrome P450 enzymes and antidepressant treatment response

M. Rietschel, K. Tansey, I. Craig, 2014, Journal of psychopharmacology.

What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram

A. Serretti, S. Kasper, G. Papadimitriou, 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression

Julien Mendlewicz, Siegfried Kasper, Alessandro Serretti, 2011, Psychiatry Research.

5-HT2a receptor polymorphism gene in bipolar disorder and harm avoidance personality trait.

F Hentges, J. Mendlewicz, D. Souery, 2000, American journal of medical genetics.

A European multicenter association study of HTR2A receptor polymorphism in bipolar affective disorder.

R. Kaneva, A. Serretti, V. Milanova, 2000, American journal of medical genetics.

Temperament and Character Inventory (TCI) personality profile and sub-typing in alcoholic patients: a controlled study.

P. Verbanck, D. Souery, I. Massat, 2001, Alcohol and alcoholism.

Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder.

C. Stefanis, G. Papadimitriou, J. Mendlewicz, 1999, Psychiatric genetics.

Treatment-resistant depression.

M. Trivedi, D. Souery, G. Papakostas, 2006, The Journal of clinical psychiatry.

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression

Pia Baldinger, Rupert Lanzenberger, Julien Mendlewicz, 2015, European Neuropsychopharmacology.

Glucocorticoid Receptor Gene-Based SNP Analysis in Patients with Recurrent Major Depression

Julien Mendlewicz, Jurgen Del-Favero, Christine Van Broeckhoven, 2006, Neuropsychopharmacology.

High occupational level is associated with poor response to the treatment of depression: A replication study

A. Serretti, L. Mandelli, S. Kasper, 2019, European Neuropsychopharmacology.

Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.

A. Serretti, S. Kasper, J. Mendlewicz, 2018, Journal of affective disorders.

Predominant polarity in bipolar disorder patients: The COPE bipolar sample.

A. Serretti, D. Souery, E. Vieta, 2019, Journal of affective disorders.

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study

A. Serretti, L. Bartova, U. Rabl, 2016, European Neuropsychopharmacology.

Social adjustment among treatment responder patients with mood disorders.

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Journal of affective disorders.

Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression

A. Serretti, L. Bartova, S. Kasper, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression

A. Serretti, L. Bartova, S. Kasper, 2020, The international journal of neuropsychopharmacology.

Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder

A. Serretti, D. Souery, J. Zohar, 2013, European Neuropsychopharmacology.

A. Serretti, L. Mandelli, L. Bartova, 2021, Depression and anxiety.

Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.

A. Serretti, L. Bartova, S. Kasper, 2018, Journal of affective disorders.

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.

A. Serretti, L. Bartova, S. Kasper, 2017, Journal of psychiatric research.

The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment – a European multicentre study

A. Serretti, S. Kasper, J. Mendlewicz, 2016, International clinical psychopharmacology.

Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study

A. Serretti, S. Kasper, J. Mendlewicz, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

Rupert Lanzenberger, Julien Mendlewicz, Thomas Vanicek, 2017, The Journal of clinical psychiatry.

A New Prediction Model for Evaluating Treatment-Resistant Depression.

Rupert Lanzenberger, Julien Mendlewicz, Thomas Vanicek, 2017, The Journal of clinical psychiatry.

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

J. Mendlewicz, D. Souery, P. Oswald, 2006, International clinical psychopharmacology.

Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder

A. Serretti, S. Kasper, J. Mendlewicz, 2013, European Archives of Psychiatry and Clinical Neuroscience.

Treatment-resistant mood disorders: The characterization and definition of treatment-resistant mood disorders

J. Mendlewicz, D. Souery, I. Massat, 2001 .

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response

D. Rujescu, A. Serretti, S. Kasper, 2021, European Neuropsychopharmacology.

The serotonin transporter and the activity regulated cytoskeleton‐associated protein genes in antidepressant response and resistance: 5‐HTTLPR and other variants

A. Serretti, S. Kasper, J. Mendlewicz, 2018, Human psychopharmacology.

Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.

M. Trivedi, D. Nutt, Y. Lecrubier, 2006, The Journal of clinical psychiatry.

Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd).

F. Bellivier, D. Souery, M. Gonzalez, 2013, The international journal of neuropsychopharmacology.

Role of risperidone in the treatment of bipolar disorder

D. Souery, M. Barreto, 2006 .

A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.

A. Serretti, Y. Lecrubier, S. Kasper, 2011, Journal of affective disorders.

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

D. Rujescu, G. Kranz, A. Serretti, 2018, Acta psychiatrica Scandinavica.

Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study

M. Nöthen, T. Schulze, C. Stefanis, 2001, Biological Psychiatry.

European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors

A. Serretti, Marina Heiden, D. Blackwood, 1998, Psychiatric Genetics.

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder

A. Serretti, L. Bartova, S. Kasper, 2018, Acta psychiatrica Scandinavica.

Definitions and Predictors of Treatment‐resistant Depression

S. Kasper, D. Souery, S. Montgomery, 2013 .

Definitions and Predictors of Treatment- resistant Depression ChaPTer 1

D. Souery, W. Pitchot, 2013 .

Opinion paper: poor response to treatment of depression in people in high occupational levels

A. Serretti, L. Mandelli, S. Kasper, 2018, Psychological Medicine.

Current issues in bipolar disorder: A critical review

Y. Lecrubier, S. Kasper, J. Mendlewicz, 2007, European Neuropsychopharmacology.

Family history of major depression and residual symptoms in responder and non-responder depressed patients.

A. Serretti, S. Kasper, J. Mendlewicz, 2014, Comprehensive psychiatry.

Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance

A. Young, A. Fagiolini, S. Kasper, 2020, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Relationship between the Newcastle scale and sleep polysomnographic variables in major depression: a controlled study

P. Linkowski, M. Kerkhofs, D. Souery, 1995, European Neuropsychopharmacology.

Temperament and character influence on depression treatment outcome.

D. Rujescu, A. Serretti, S. Kasper, 2019, Journal of affective disorders.

Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression.

S. Claes, J. Mendlewicz, D. Souery, 2002, American journal of medical genetics.

Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputation

M. Rietschel, R. Weinshilboum, A. McIntosh, 2023, medRxiv.

Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study

A. Serretti, L. Bartova, S. Kasper, 2020, European Neuropsychopharmacology.

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder

Y. Lecrubier, S. Kasper, J. Mendlewicz, 2011, International clinical psychopharmacology.

Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study.

A. Serretti, L. Bartova, S. Kasper, 2021, Journal of affective disorders.

Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression.

A. Serretti, S. Kasper, J. Mendlewicz, 2015, Journal of affective disorders.

Age as a moderating factor of treatment resistance in depression

D. Rujescu, A. Serretti, L. Bartova, 2023, European Psychiatry.

Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.

D. Rujescu, A. Serretti, L. Bartova, 2023, Journal of affective disorders.

Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database.

A. Serretti, L. Bartova, S. Kasper, 2023, Journal of affective disorders.

Pharmacogenetics of bipolar disorders

J. Mendlewicz, D. Souery, P. Oswald, 2006 .

High occupational level is associated with poor response to treatment of depression

A. Serretti, L. Mandelli, S. Kasper, 2016, European Neuropsychopharmacology.

Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study

A. Serretti, Y. Lecrubier, S. Kasper, 2010, International clinical psychopharmacology.

Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder

D. Rujescu, A. Serretti, L. Bartova, 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Melancholic features in major depression – a European multicenter study

A. Serretti, L. Bartova, S. Kasper, 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes

Y. Lecrubier, S. Kasper, J. Mendlewicz, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Assessing 42 inflammatory markers in 321 control subjects and 887 major depressive disorder cases: BMI and other confounders and overall predictive ability for current depression

M. Rietschel, D. Collier, M. Hotopf, 2018, bioRxiv.

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study

A. Serretti, L. Bartova, S. Kasper, 2018, European Neuropsychopharmacology.

Attrition in treatment-resistant depression: predictors and clinical impact.

A. Serretti, S. Kasper, J. Mendlewicz, 2019, International clinical psychopharmacology.

Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts

D. Rujescu, M. Kas, A. Serretti, 2021, International clinical psychopharmacology.

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample

A. Serretti, S. Kasper, J. Mendlewicz, 2015, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study

R. Kaneva, F. Bellivier, A. Serretti, 2007, Molecular Psychiatry.

COMT and age at onset in mood disorders: A replication and extension study

A. Serretti, S. Kasper, J. Mendlewicz, 2011, Neuroscience Letters.

Compliance and therapeutic issues in resistant depression

J. Mendlewicz, D. Souery, 1998, International clinical psychopharmacology.

P.179 Polygenic risk scores for multiple psychiatric, inflammatory and cardio-metabolic traits highlight possible genetic overlap with suicide attempt

D. Rujescu, A. Serretti, D. Wasserman, 2020, European Neuropsychopharmacology.

Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depression

D. Rujescu, K. Domschke, D. Souery, 2023, medRxiv.

P.171 Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder

D. Rujescu, A. Serretti, S. Kasper, 2020, European Neuropsychopharmacology.

The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression.

A. Serretti, L. Mandelli, L. Bartova, 2021, Journal of affective disorders.

Exploring the role of drug-metabolising enzymes in antidepressant side effects

M. Rietschel, K. Tansey, I. Craig, 2015, Psychopharmacology.

Mixed, melancholic, and anxious features in depression: a cross-sectional study of sociodemographic and clinical correlates.

A. Serretti, S. Kasper, J. Mendlewicz, 2014, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Prise en charge thérapeutique des patients présentant un trouble bipolaire en France et en Europe : étude multinationale longitudinale WAVE-bd

F. Bellivier, D. Souery, E. Vieta, 2014 .

[Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].

D. Souery, E. Vieta, M. Figueira, 2014, L'Encephale.

Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project

M. Rietschel, T. Schulze, I. Craig, 2009, Neuropsychopharmacology.

No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: Evidence from Belgian first and replication patient–control studies

C. Broeckhoven, S. Claes, J. Mendlewicz, 2005, European Neuropsychopharmacology.

Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression

A. Serretti, Y. Lecrubier, S. Kasper, 2011, Journal of clinical psychopharmacology.

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies

M. Rietschel, K. Tansey, I. Craig, 2018, European Neuropsychopharmacology.

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

M. Rietschel, K. Tansey, G. Breen, 2017, The Pharmacogenomics Journal.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study

S. Kasper, J. Mendlewicz, D. Souery, 2010, International clinical psychopharmacology.

Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis

E. Constant, P. Sienaert, S. Claes, 2012, Journal of psychopharmacology.

Association between novelty-seeking and the dopamine D3 receptor gene in bipolar patients: a preliminary report.

D. Souery, C. Hilger, J. Monreal, 1998, American journal of medical genetics.

The Multiple Facets of Treatment-Resistant Depression

D. Souery, Karel Van der Auwera, 2004, CNS Spectrums.

Dissociation in Major Depressive Disorder: A Pilot Study

Daniel Souery, D. Souery, S. Linotte, 2008, Journal of trauma & dissociation : the official journal of the International Society for the Study of Dissociation.

Introduction to the Special Section. New advances in the understanding and treatment of bipolar disorder.

J. Mendlewicz, D. Souery, 2003, The international journal of neuropsychopharmacology.

Temperament and Character Inventory (TCI) personality profile and sub-typing in alcoholic patients: a controlled study.

P. Verbanck, D. Souery, I. Massat, 2001, Alcohol and alcoholism.

Lack of association between the 5HT 2A receptor polymorphisms ( T102C) and unipolar affective disorder in a multicentic European study

R. Kaneva, A. Serretti, V. Milanova, 2003 .

Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples

D. Souery, P. Ferentinos, S. Porcelli, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Validation of the Newcastle Scale through sleep polysomnographic studies in major depression: comparison with age matched controls

P. Linkowski, M. Kerkhofs, D. Souery, 1993, European Neuropsychopharmacology.

Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.

M. Rietschel, A. Farmer, P. McGuffin, 2011, Journal of affective disorders.

Combining clinical variables to optimize prediction of antidepressant treatment outcomes.

M. Rietschel, A. Farmer, P. McGuffin, 2016, Journal of psychiatric research.

[Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].

F. Bellivier, D. Souery, E. Vieta, 2014, L'Encephale.